Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Nottingham Post
Nottingham Post
World
Robbie Purves

Ozempic weight loss jab users complain of new 'shrinking finger' side effect

Many using weight loss injections are now complaining of a side effect called 'Ozempic finger' which becomes a problem once users have shed extra pounds. The weight loss injections have been shown to help those taking the medicine to lose significant amounts of weight and will now be available on the NHS.

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication, which is now being used for weight loss. It works by mimicking a hormone called glucagon-like peptide 1 (GLP-1) that targets the area of the brain responsible for regulating appetite. It means you are less hungry and therefore eat less food.

According to a report in the New York Post, some people taking Semaglutide jabs are complaining of 'Ozempic finger'. This occurs when someone loses weight rapidly, causing fat loss in the person's fingers which can mean things like wedding rings no longer fit and have even slipped off altogether.

Jewellery retailers have witnessed a surge of 150 per cent in customer demand for downsizing rings and bracelets when compared to the previous year. Talking to the New York newspaper, jeweller Melanie Fitzpatrick said: "Usually the summer is a very quiet time for jewellers, but this year we are seeing a huge influx of jewellery repairs due to clients losing weight."

Ozempic finger is not the only side effect users have complained of, with 'Ozempic face' also something those who take the injections have noticed. Typically, Ozempic face is down to your body losing fat, which leaves your face looking less full.

In the UK, Semaglutide has been approved for NHS use by the National Institute for Health and Care Excellence. It will be recommended to people with at least one weight-related health condition.

As well as those who have a body mass index (BMI) which is near the top of the obese range. Though Semaglutide products have been very efficient in medical trials, they do come with health warnings.

According to Ozempic, it can 'lead to possible thyroid tumours, cancer, pancreatitis, changes in vision, serious allergic reactions, kidney problems and gallbladder issues'. The most common side effects include nausea, vomiting, diarrhoea, stomach pain and constipation.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.